Get the app!
Back to Trades
Grant4

HALOZYME THERAPEUTICS, INC.

HALO

Total Value
$397.9K

Company Information

Ticker Symbol
HALO
CIK
0001159036

Insider Information

Role
Director
Director
Location
SAN DIEGO, CA

Filing Details

Filing Date
May 7, 2026
Transaction Date
May 5, 2026
Accession Number
0001159036-26-000063
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
May 5, 2026Common Stock3,796Grant/Award

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
May 5, 2026Derivative6,040$65.87Grant/Award$397.9K

Footnotes

  1. (F1)Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.
  2. (F2)Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.